Browsing by Author Gazi, I.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 20 to 25 of 25 < previous 
TitleAuthor(s)Issue date???itemlist.???
Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particlesTsimihodimos, V.; Gazi, I.; Kostara, C.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Plasma PAF-acetylhydrolase(Lp-PLA(2)) activity as a marker of small-dense LDL in subjects at median cardiovascular riskFilippatos, T. D.; Gazi, I.; Kiortsis, D. N.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Plasma triglyceride levels and body mass index values are the most important determinants of pre beta-1 HDL concentrations in patients with various types of primary dyslipidemiaTsimihodimos, V.; Gazi, I.; Filippatos, T.; Kostapanos, M.; Lagos, K.; Kostara, C.; Tellis, C. C.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Quantitative and qualitative changes of serum lipoproteins in patients with acute brucellosisApostolou, F.; Liberoloulos, E.; Gazi, I.; Tsouli, S.; Tsianos, E.; Tselepis, A.; Elisaf, M. S.24-Nov-2015-
Rosuvastatin administration decreases apolipoprotein CII and CIII serum levels in patients with primary dysilipidaemiaKostapanos, M.; Filippatos, T.; Gazi, I.; Saougos, V. G.; Milionis, H. J.; Kostara, C.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015-
Rosuvastatin increases alpha-1 microglobulin urinary excretion in patients with primary dyslipidemiaKostapanos, M. S.; Milionis, H. J.; Gazi, I.; Kostara, C.; Bairaktari, E. T.; Elisaf, M. S.24-Nov-2015-